Tablets comprising candesartan cilexetil

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 31/4184 (2006.01) A61K 31/54 (2006.01) A61K 47/14 (2006.01) A61K 47/34 (2006.01) C07D 413/10 (2006.01)

Patent

CA 2654493

Composition in the form of a tablet, comprising candesartan cilexetil and optionally further active agents and usual adjuncts, wherein the surface of at least the active agent candesartan cilexetil in this composition is provided with a coating, made from a compound or a mixture of compounds selected from tri-(C1-C6) alkyl citrate, di-(C1- C6) alkyl phthalate, di-(C1-C6) alkyl sebacate and polydimethysiloxanes and methods for production thereof.

L'invention concerne une composition sous forme d'un comprimé, renfermant du candesartan cilexetil et, éventuellement, d'autres principes actifs, ainsi que des substances d'addition courantes, caractérisée en ce que dans ladite composition, la surface au moins du principe actif candesartan cilexetil est pourvue d'un enrobage constitué par un composé ou par un mélange de composés, sélectionnés à partir d'un trialkyl (C1-C6) citrate, d'un dialkyl (C1-C6) phtalate, d'un dialkyl (C1-C6) sébaçate et de polydiméthylsiloxanes. L'invention concerne en outre un procédé de fabrication de la composition précitée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tablets comprising candesartan cilexetil does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tablets comprising candesartan cilexetil, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tablets comprising candesartan cilexetil will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1762510

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.